Resistant hypertension: time to consider the best fifth anti-hypertensive treatment (2018)
- Authors:
- Autor USP: DRAGER, LUCIANO FERREIRA - FM
- Unidade: FM
- DOI: 10.1007/s11906-018-0866-y
- Subjects: HIPERTENSÃO; ESTUDOS MULTICÊNTRICOS; FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
- Language: Inglês
- Imprenta:
- Source:
- Título: Current hypertension reports
- ISSN: 1522-6417
- Volume/Número/Paginação/Ano: v. 20, n. 8, article ID 67, 4p, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PIO-ABREU, Andrea e DRAGER, Luciano Ferreira. Resistant hypertension: time to consider the best fifth anti-hypertensive treatment. Current hypertension reports, v. 20, n. 8, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11906-018-0866-y. Acesso em: 22 jan. 2026. -
APA
Pio-abreu, A., & Drager, L. F. (2018). Resistant hypertension: time to consider the best fifth anti-hypertensive treatment. Current hypertension reports, 20( 8). doi:10.1007/s11906-018-0866-y -
NLM
Pio-abreu A, Drager LF. Resistant hypertension: time to consider the best fifth anti-hypertensive treatment [Internet]. Current hypertension reports. 2018 ; 20( 8):[citado 2026 jan. 22 ] Available from: https://doi.org/10.1007/s11906-018-0866-y -
Vancouver
Pio-abreu A, Drager LF. Resistant hypertension: time to consider the best fifth anti-hypertensive treatment [Internet]. Current hypertension reports. 2018 ; 20( 8):[citado 2026 jan. 22 ] Available from: https://doi.org/10.1007/s11906-018-0866-y - Rationale and methodology of the SARAH Trial: Long-term cardiovascular outcomes in patients with resistant hypertension and obstructive sleep apnea
- Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial: data from the GATEWAY trial
- Bariatric Surgery for Resistant Hypertension: Working in Progress!
- OSA and cardiometabolic risk: What's the bottom line?
- Are we missing obstructive sleep apnea diagnosis?[Editorial]
- Apneia Obstrutiva do Sono e Aterosclerose: uma abordagem translacional
- Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic: a nationwide cross-sectional study in Brazilian health care professionals
- OSA and Prognosis After Acute Cardiogenic Pulmonary Edema The OSA-CARE Study
- Obstructive Sleep Apnea and Diabetes Independently Add to Cardiovascular Risk After Coronary Revascularization [Carta]
- Is obstructive sleep apnoea an innocent bystander in the pathophysiology of arterial stiffening? [Editorial]
Informações sobre o DOI: 10.1007/s11906-018-0866-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
